Facebook
Instagram
Pinterest
Reddit
Tumblr
X
Youtube
Home
About
News
Events
Shop
Directory
Contact Us
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
PsyNews.com
Home
About
News
Events
Shop
Directory
Contact Us
Home
Featured
Page 261
Featured
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Pα+ Psychedelic Bulletin #225: Q1 Lobbying Update; Individual vs. Group MDMA Therapy Study Launches; Australia Loosens Psychedelics Access Regulations; VA Launches “New” MDMA Trial
Three Brain Injuries, One Iboga Protocol, and What It Tells Us
The War on Drugs Was Never About Drugs. Psychedelic Healing Must Reckon With That.
A Dispatch from APA’s Annual Meeting: Psychedelics Return at an Awkward Moment for American Psychiatry
Momentum Amidst Tumult: The FDA Reshuffle, Approval Timelines, and the Compass-Usona Race
Field Trip Health Ltd. Applies to List Its Common Shares on...
PT247 – Julian Vayne – Magic, Prohibition, and New Models for...
Tolerance, Tachyphylaxis, and Psychedelic Drug Action
Psychedelic Bulletin: Poll Shows Support for Psilocybin in the UK; Psychedelics-tinged...
Delix Therapeutics Announces Scientific & Strategic Advisory Board Appointments
PTSF62 – Senate Bill 519, Ketamine, and Psilocybin-producing Cicadas
Op-ed: UK Public Support Psilocybin Research & Rescheduling Despite Government Stance
Field Trip Health Ltd. to Commence Trading on the Toronto Stock...
MINDCURE Successfully Completes First Stage of Manufacturing Synthetic Ibogaine for Use...
Silo Wellness Partners with Mushe Inc. to Establish First Legal Brick...
Load more